Israel Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

  • Published : Aug 2022
  • Report Code : KSI061613405
  • Pages : 90

Israeli’s infection control market is evaluated at US$98.025 million for the year 2020 and is projected to grow at a CAGR of 7.86% to reach a market size of US$166.469 million by the year 2027.

Owing to a surge in various startups, favourable investment policies from the government, and being ranked 35 in the world as far as the ease of doing business is concerned, with the classification of “Very Easy,” Israel has been witnessing steady growth in its tourism sector. To this end, it is pertinent to mention that in January 2020, there were 308.5 thousand tourist arrivals. This figure is up 8% from last year. This number is up 8% over 2019. There were 285.6 entries in January, up 20% from 2018 when 256.6 entries were recorded in January. The revenue from tourists in January 2020 is estimated at $ 437 million, which is about $ 1.5 billion. The number of overnight stays at tourist hotels - continues to be higher than in the preceding year. In 2019, a record 12.1 million tourist stays were recorded - a 5% increase over 2018, the year in which the number of tourist stays was the highest since 2008. A record 25.8 million in the number of overnight stays (total Israelis and tourists) were recorded in tourist hotels in Israel in 2019. That is an increase of 3% compared to 2018. In December 2019, room occupancy was up 61% from 60% in December 2018 - up by 1.7%.

Further, The average room occupancy for 2019 was 70%, compared to 68% on average in 2018. According to an incoming tourism survey, in 2018, 55.9% of all tourists stayed at a hotel. Israel ranks 25th out of 35 countries, including Mexico, Turkey, Spain, and Portugal, where tourism services exports account for more than half of total services exports.  

Further, In January 2020, a total of 1.65 million person-nights of Israelis and tourists were registered in tourist hotels in Israel, an increase of 2.9% compared to the number of nights in January 2019 and an increase of 5.6% compared to the number of nights in January 2018. Compared to last year, the occupancy rate in tourist hotels in January was 55.9%, up 0.7%. However, with the advent of the global pandemic, the Israeli government put certain travel restrictions in place that have hindered the growth; as estimated by the World Tourism Organization already that the tourism movement in 2020 will decrease by at least 3% -1% With a loss of $ 30-50 billion in revenue, assuming the crisis will carry similar characteristics to the SARS epidemic in 2003, the worsening crisis will increase the damage accordingly. IATA estimates that airlines will suffer losses of at least $ 63 billion, and maybe even more so if the situation continues. The aforesaid is in the global context. This can be a deterrent to the tourism sector.

Nevertheless, from the facts mentioned above and the figures, a clear picture emerges whereby it can be determined that the tourism sector had healthy growth. Further, the rise in annual income and occupancy percentage from tourists depicted by the graph below clearly shows the room for the growth of the tourism sector in the forecast period. Therefore, to make way for the growth and prevent a possible dent in the trajectory towards the same, the establishment of accommodations as well as standalone food and beverage establishments are required to heavily invest in infection control products, thereby ensuring a memorable experience for their clients while simultaneously ensuring future revenue growth for their business. Thus, this health imperative of various stakeholders in the tourism sector is poised to push the infection control market of Hungary to unprecedented heights during the forecast period.

COVID-19 SCENARIO

The COVID-19 epidemic has significantly impacted the market for infection control in Israel. Worldwide, healthcare systems have been devastated by the pandemic, with hospitals becoming overcrowded as patient numbers rise. Temporary hospitals are being built to handle the influx of cases. The spread of COVID-19 has caused a boom in demand for cleaning and disinfection products because of the heightened awareness about cleanliness, health, and safety. However, it is anticipated that the infection control business will suffer severely post-COVID.

Key Developments

  • May 2020- Israeli researchers create a corona-busting disinfectant that endures. The new compounds target the virus infection mechanism and last longer than chlorine bleach and comparable surface disinfection solutions.
  • April 2020- According to Israeli experts, tap water can be used to manufacture a disinfectant. Israeli researchers develop a long-lasting corona-busting disinfectant. The novel compounds stay longer than chlorine bleach and other comparable surface disinfection products because they target the virus infection mechanism.

Israel Infection Control Market Scope:

 

Report Metric Details
 Market Size Value in 2020  US$98.025 million
 Market Size Value in 2027  US$166.469 million
 Growth Rate  CAGR of 7.86% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Million
 Segments Covered  Product, And End-User Industry
 Companies Covered  3M, ASP, Inter-Lab Ltd. (Merck KGaA), Cardinal Health, Tuttnauer
 Customization Scope  Free report customization with purchase

 

Market Segmentation:

  • By Product
    • Disinfectant
    • Sterilization
      • Low temperature Sterilization
      • Heat Sterilization
      • Contract Sterilization
  • By End User Industry
    • Healthcare
    • Food and Beverage
    • Chemical

1. Introduction
1.1.  Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2.  Research Methodology
2.1.  Research Data
2.2.  Assumptions

3.  Executive Summary
3.1.  Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4.  Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Israel Infection Control Market by Product
5.1.  Introduction
5.2. Disinfectant
5.3. Sterilization 
5.3.1.  Low-Temperature Sterilization
5.3.2.  Heat Sterilization
5.3.3. Contact Sterilization

6. Israel Infection Control Market by End-User Industry
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical

7. Competitive Environment and Analysis
7.1. Major Players and Strategy Analysis
7.2.  Emerging Players and Market Lucrativeness
7.3.  Mergers, Acquisitions, Agreements, and Collaborations
7.4.  Vendor Competitiveness Matrix

8. Companies Profiles
8.1. 3M                                     
8.2. ASP                                     
8.3. Inter-Lab Ltd. (Merck KGaA)     
8.4. Cardinal Health                
8.5. Tuttnauer     

3M                                     

ASP                                    

Inter-Lab Ltd. (Merck KGaA)    

Cardinal Health             

Tuttnauer